Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Larsen syndrome: a case report
In mouse models of insulin resistance, it significantly inhibits NNMT activity in liver and muscle, reduces NAM methylation, increases intracellular NAD+, activates the SIRT1 pathway, promotes phosphorylation of insulin receptor substrate 1 (IRS1), enhances insulin signaling, improves insulin sensitivity, and increases glucose uptake and utilization
10mg vial / 8mg per week = 1.25 weeks
Summary: GHK-Cu UK is a copper-binding tripeptide research compound investigated in cellular signalling, tissue remodelling and protein expression pathways within controlled laboratory environments
US$ 24.57
US$ 24.27
US$ 24.72
US$ 21.40
US$ 28.55
